17 December 2025VideosEuropeCharles Larsen, McDermott Will & Emery | Marcus Dalton, Curevac | Shohta Ueno, Regeneron | Rachel Fetches, HGF | Edger Brinkman, Unified Patent Court

WATCH: Behind the scenes of big ticket litigation — lessons from the courts

High-value IP disputes are reshaping life sciences litigation, with perspectives from McDermott Will & Emery, Curevac, Regeneron, HGF, and the UPC.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com

More on this story

Europe

UPC revives patent, but timing sinks Guardant’s appeal

6 July 2026 The Unified Patent Court delivers a mixed ruling in a dispute over liquid biopsy technology, overturning a finding that a patent was likely invalid while refusing to grant interim relief because of the patent owner’s delay.

Europe

Exclusive: ‘Cultural differences are an asset’ at the UPC

16 June 2026 In the second of a series of interviews with women judges at the pan-European court, Ulrike Voß talks to Sarah Speight about her career, her views on the court so far, and how more women could be encouraged to join the judiciary.

Europe

Exclusive: ‘When a UPC judge wears their robe, they have no gender’

9 June 2026 In the second of a series of interviews with women judges at the Unified Patent Court, Carine Gillet shares her views with Sarah Speight on encouraging more women into technical judicial careers, how equipped the court is to handle life sciences disputes, and more.

More features

UPC upholds injunction in Invisalign maker’s software dispute with rival

BioNTech and Pfizer secure big European win over mRNA patent

UPC revives patent, but timing sinks Guardant’s appeal

HGF expands European offering with pair of in-house hires

Merck KGaA agrees $11.3bn deal in major life sciences expansion

Novartis and Eli Lilly sign separate $1.9bn novel drug deals

Novo secures website blocking to tackle fake weight-loss drugs

Insilico lands potential $2.5bn AI biotech partnership

WATCH: Behind the scenes of big ticket litigation — lessons from the courts

More on this story

Editor's picks

Editor's picks

More features